This is getting a bit convoluted. What are the commercial gains from making deadly viruses? Isn’t that the sort of things that the military do and are national security concerns?
Anyway, at the moment I would rather spend more time looking at the fascinating part played by ACE2 as the receptor for the spike protein in SARS-cov-2 and the possible therapeutic implications of disrupting this interaction. Although there has been a lot of talk about a vaccine, the targeting of this interaction to try and reduce virus entry is something that can be achieved in a shorter time than a vaccine.